CELZ Creative Medical Technology Year-over-year earnings per share growth for the last twelve months

The quarterly EPS trajectory demonstrates profit dynamics, with the figure recorded at 16.60. Creative Medical Technology (CELZ) management aims to commercialize patents in the fields of diabetes therapy and erectile dysfunction. The company is currently scaling its cellular platform through clinical trials in the US. Success is driven by a tight-knit environment of top researchers motivated by stock option programs and a high degree of autonomy.

creativemedicaltechnology.com (CELZ) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 11/10/2026

Creative Medical Technology - analytical breakdowns and key metrics (CELZ)

- share price and expert price forecast:

Stock Price creativemedicaltechnology.com|CELZ - Consensus Target

- market capitalization data:

Market Value Creative Medical Technology Holdings Inc.|CELZ - Value Adjusted for Debt and Cash

- book capitalization data:

Book Value per Share Creative Medical Technology|CELZ - Total Stockholders' Equity|Market Capitalization to Book Value Ratio creativemedicaltechnology.com|CELZ - Company Total Assets

- business debt structure and liquidity details:

Total Debt to Equity Ratio Creative Medical Technology|CELZ - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital creativemedicaltechnology.com|CELZ - Company Total Debt Obligations|Debt to Book Value Creative Medical Technology Holdings Inc.|CELZ - Company Long-Term Debt|Company Short-Term Debts Creative Medical Technology|Quick Liquidity Indicator creativemedicaltechnology.com

- earnings and valuation multiples indicators:

CELZ - Final Profit|Expected Profit Creative Medical Technology|CELZ - Price to Earnings Ratio|Forward P/E Multiple creativemedicaltechnology.com|CELZ - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Creative Medical Technology Holdings Inc.|CELZ - Operating profit before amortization|Net earnings per share (EPS TTM) Creative Medical Technology|CELZ - Net earnings per share for the last four quarters|Quarterly EPS earnings growth creativemedicaltechnology.com|CELZ - Net earnings per share growth this year|Earnings growth forecast for next year Creative Medical Technology

Analysis of all company metrics:Creative Medical Technology Holdings, Inc., CELZ

Finished products of Creative Medical Technology

The competitiveness of Creative Medical Technology (CELZ) is based on innovations in regenerative medicine and patents for the treatment of diabetes and erectile dysfunction. Quantifying this progress through quarterly growth in net income per share reveals the actual effectiveness of clinical trial commercialization, while shifts in quarterly EPS dynamics signal emerging trends or the risk of stagnation even amidst apparent price stability.

Direct competitors

MESO: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Lineage Cell Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months Surrozen Corp|CCEL: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth FBLG|LGVN - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth BRTX (BioRestorative Therapies, Inc.)